DexCom (DXCM)
(Delayed Data from NSDQ)
$76.55 USD
+0.97 (1.28%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $76.67 +0.12 (0.16%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth C Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, DexCom, Inc. has a market cap of $29.64B, which represents its share price of $75.58 multiplied by its outstanding shares number of 392.15M. As a large-cap company, DXCM's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
DXCM 76.55 +0.97(1.28%)
Will DXCM be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for DXCM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DXCM
Investing in the Age of Longevity: Silver Economy Stocks in Focus
Why Is DexCom (DXCM) Down 7% Since Last Earnings Report?
DXCM: What are Zacks experts saying now?
Zacks Private Portfolio Services
DexCom Expands Access and Innovation While Balancing Headwinds
Trinity Biotech's Redesigned CGM Sensor Favored by New Clinical Data
Abbott's Q2 Diabetes Care Sales Rise 19.6%: What's Backing It?
Other News for DXCM
DexCom, Inc. (DXCM) Announces Temporary Leadership Changes Amid CEO's Medical Leave
DXCM forms 20 Day Moving Average Resistance on September 15
DexCom (DXCM) Appoints Interim CEO Amid Executive Medical Leave
DexCom CEO takes medical leave
Dexcom CEO Takes Medical Leave, Interim Roles Announced